Mon, Feb. 23, 4:17 PM| Comment!
Mon, Feb. 23, 12:07 PM
- Among the additions to the index (which fuels the IBLN ETF) are EMC, Google (GOOG, GOOGL), Goodyear (NASDAQ:GT), Mohawk Industries (NYSE:MHK), PVH, Time Warner (NYSE:TWX), and Yahoo (NASDAQ:YHOO). There are three health care additions as well: Allergan (NYSE:AGN), Amgen (NASDAQ:AMGN), and HCA. The lone energy name added is Consol Energy (NYSE:CNX).
- Exiting the index are energy names Halliburton (NYSE:HAL) and National-Oilwell Varco (NYSE:NOV), along with healthcare companies AbbVie (NYSE:ABBV), Aetna (NYSE:AET), Humana (NYSE:HUM), and Tenet Healthcare (NYSE:THC). Citigroup (NYSE:C), CBS, Crown Castle (NYSE:CCI), and Michael Kors (NYSE:KORS) round out those subtracted.
- IBLN tracks the highest-conviction S&P 500 picks by hot-handed billionaires who built their fortunes through hedge funds and investing. The list of billionaires tracked is updated each October, and the equity components are rebalanced each quarter after sifting through regulatory filings.
- IBillionaire Index Rebalance
Sun, Feb. 22, 5:35 PM
Thu, Feb. 5, 9:04 AM
- Fourteen of 23 prominent hospitals contacted by Reuters have rolled out pilot programs of Apple's HealthKit service, which enables the remote monitoring of patient-generated health information, such as blood pressure, weight and heart rate, via an iPhone. The technology will potentially enable physicians detect early signs of trouble and to intervene accordingly in patients with chronic diseases like diabetes and hypertension before the situation becomes acute (and much more expensive).
- Google and Samsung have released similar services and have also begun to reach out to hospitals. This bodes well for patients and doctors alike.
- Related tickers: (NYSE:HUM) (NYSE:HCA) (NYSE:UHS) (NYSE:CYH) (NASDAQ:LPNT) (NYSE:SEM) (NYSE:ADPT) (NYSEMKT:SSY) (NYSE:THC)
Mon, Jan. 12, 10:29 AM
- Tenet Healthcare (THC -6.2%) expects adjusted EBITDA of $2.05B - 2.15B this year. For 2014, adjusted EBITDA will be toward the upper range of $1.90B - 1.95B.
- For Q4 2014, same hospital adjusted growth in admissions was 4.8%, growth in inpatient admissions was 4.0%, paying admissions grew 6.1% and outpatient visits grew 9.5%. Exchange admissions were 3,768 (+11.0%).
- 2015 Guidance: Net revenues: $17.4B - 17.7B; adjusted EPS: $1.32 - 2.40; adjusted CF Ops: $1.15B - 1.25B; capex: $900M - 1.0B; admissions growth: 1.5 - 2.5%; adjusted admissions growth: 2.5 - 3.5%; exchange volume growth: 60 - 80%; net revenue per adjusted admission growth: 1.0 - 2.0%; controllable expenses per adjusted admission growth: 0 - 1.0%.
Dec. 25, 2014, 12:18 PM
Nov. 25, 2014, 2:46 PM
- "Not surprisingly, billionaires reduced their energy allocations (NYSEARCA:XLE) during Q3," says Direxion, unveiling the quarterly rebalance for the iBillionaire Index (which serves as the benchmark for the IBLN ETF). Attention was instead shifted to healthcare (NYSEARCA:XLV) and materials (NYSEARCA:XLB), with companies like Humana (NYSE:HUM) and Monsanto (NYSE:MON).
- Also added to the index: TMO, GM, FB, CBS, GOOG, MAS, APD, DAL, NOV, WHR, THC, ABBV.
- Dropped from the index: AIG, MCK, CTSH, MSI, RIG, CI, APC, GPS, MSFT, CMCSA, NFLX, MHFI, WMB, ICE.
- Outlying sectors: Consumer Discretionary (NYSEARCA:XLY) makes up 23.33% of the iBillionaire Index vs. 11.68% for the S&P 500, and Industrials (NYSEARCA:XLI) and financials (NYSEARCA:XLF) make up just 6.67% each of the index vs. 10.44 and 16.30 of the S&P 500, respectively. Consumer Staples (NYSEARCA:XLP) have zero representation in the index vs. 9.7% in the S&P 500.
- Previously: Direxion launched an ETF with iBillionaire today
Nov. 3, 2014, 4:19 PM| Comment!
Oct. 14, 2014, 3:31 PM
- Global growth, foreign-exchange, oil, and small caps are the subject of every client inquiry, says David Kostin. His team's recommendation: Buy "American exceptionalism."
- In Kostin's view, U.S. economy and corporate fundamentals are still strong, with economic growth expected by Goldman economists to be 3.2% next year, the fastest expansion since 2005. Europe is expected to grow just 1%.
- What his team likes are those stocks of companies which have a high proportion of domestic sales, plus sectors like Consumer Staples (XLP -0.1%) and Discretionary (XLY +0.7%) which stand to benefit from lower oil prices (plunging again today).
- As for small caps (IWM +0.9%), Kostin is wary, noting downward earnings revisions have boosted small cap P/E ratios even as prices have declined.
- The list of S&P 500 names capturing two or more of Kostin's themes: GT, GM, PCLN, AMZN, CMCSA, LOW, DG, TSN, ADM, CVS, AVP, WAG, PXD, HAL, JPM, BAC, SCHW, PNC, MS, C, GNW, LNC, MET, THC, AET, UNH, ESRX, HUM, WLP, BIIB, GILD, DAL, CMI, FLR, CRM, JBL, MA, FB, MU, FSLR, VMC, MON, T.
Oct. 7, 2014, 7:52 AM| Comment!
Oct. 6, 2014, 11:18 AM
Sep. 24, 2014, 10:17 AM
Aug. 23, 2014, 7:58 AM
- Joel Greenblatt made investors fortunes at his hedge fund 30 years ago by holding a highly concentrated basket - six to eight names - of deep-value stocks, but his approach today is somewhat different: Buy more than 300 high-quality stocks trading at cheap prices and short more than 300 expensive, lower-quality names. Stocks are weighted in the portfolio depending on where they rank along that spectrum.
- Greenblatt: "[My partner] and I would wake up some days and lose 15% or 20% of our net worth ... now it's more like 15 or 20 basis points."
- The strategy is also available in a trio of mutual funds Greenblatt's Gotham Asset Management offers, and they now account for more than half of Gotham's $7B in AUM.
- A top position last year remaining a large holding after a big run higher is Apple, thanks to "huge returns on capital" and 11% earnings yield. As for Apple's future, Greenblatt will leave that for others to debate: "I don't own just Apple. I own a bucket of companies like Apple, and over time, I know my bucket is going to work."
- Top 5 long holdings now: ENR, SAFM, BG, AXE, CAT.
- Top 5 short holdings now: SUSS, THC, BOBE, KMT, TMO.
Aug. 4, 2014, 5:07 PM
- Tenet Healthcare Corp. (THC +1.9%) Q2 results: Net Operating Revenues: $4,042M (+66.9%); Operating Income: $207M (+2.5%); Net Loss: ($26M) (+48.0%); Loss Per Share: ($0.27) (+51.0%); Quick Assets: $406M (+259.3%); CF Ops: $247M (+93.0%).
- 2014 Guidance: non-GAAP EBITDA: $1.85B - 1.95B.
- Q3 Guidance: non-GAAP EBITDA: $400M - 450M; EPS: ($0.30) - $0.21.
Aug. 4, 2014, 4:24 PM
Aug. 3, 2014, 5:35 PM
- ACLS, ACXM, AEIS, AIG, ANV, APL, AREX, BRS, CAR, CHGG, CKEC, CKP, CNQR, CRK, CUTR, DRC, ECOM, ELNK, ENH, EOX, EPAM, GTAT, ININ, IRWD, JMBA, KAMN, KONA, LF, LLNW, LMNS, MCEP, MDR, MRO, MWA, NLS, OGS, OTTR, PHH, PL, PLOW, PXD, QLYS, REGI, ROSE, RP, RTEC, SALE, SNHY, THC, TNET, TNET, TSRA, TXRH, VNO, VNR, VVC, WAGE, Y
THC vs. ETF Alternatives
Other News & PR